Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 8/20 | 0.53 |
| ▸ | MEN1 | O00255 | 7/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.53 |
| ▸ | GAA | P10253 | 3/20 | 0.53 |
| ▸ | THRB | P10828 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | ACHE | P22303 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30342922 | 0.87 | ALDH1A1 (0.70) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL31502131 | 0.87 | ALDH1A1 (0.70) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL31502238 | 0.84 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30342609 | 0.80 | MEN1 (0.43) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30342710 | 0.79 | MEN1 (0.41) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30342677 | 0.79 | PTK6 (0.44) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30342530 | 0.77 | MAPT (0.47) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30342705 | 0.76 | ALDH1A1 (0.60) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30342781 | 0.76 | LMNA (0.72) | MAPTMEN1KMT2AALDH1A1KDM4E | |
| SCHEMBL30342643 | 0.75 | KMT2A (0.44) | MAPTMEN1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250129015-A1 | HALOGENATED BENZYLIDINE DERIVATIVES | Renovel Innovations, Inc. (US) | 2025-04-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250129015-A1 | HALOGENATED BENZYLIDINE DERIVATIVES | BRD2, MPO, BRD9 | MAPT 4063/4885MEN1 4770/4885KMT2A 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.